152 related articles for article (PubMed ID: 38422655)
1. Targeting Nrf2 to treat thyroid cancer.
Gong Z; Xue L; Li H; Fan S; van Hasselt CA; Li D; Zeng X; Tong MCF; Chen GG
Biomed Pharmacother; 2024 Apr; 173():116324. PubMed ID: 38422655
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls antioxidant transcriptional responses and viability of cancer cells.
Ziros PG; Manolakou SD; Habeos IG; Lilis I; Chartoumpekis DV; Koika V; Soares P; Kyriazopoulou VE; Scopa CD; Papachristou DJ; Sykiotis GP
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1422-7. PubMed ID: 23766517
[TBL] [Abstract][Full Text] [Related]
3. NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer.
Zhang TT; Qu N; Sun GH; Zhang L; Wang YJ; Mu XM; Wei WJ; Wang YL; Wang Y; Ji QH; Zhu YX; Shi RL
Int J Oncol; 2018 Aug; 53(2):685-693. PubMed ID: 29901070
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Nrf2 promotes the antitumor effect of Pinelliae rhizome in papillary thyroid cancer.
Du Z; Wang Q; Ma G; Jiao J; Jiang D; Zheng X; Qiu M; Liu S
J Cell Physiol; 2019 Aug; 234(8):13867-13877. PubMed ID: 30697724
[TBL] [Abstract][Full Text] [Related]
5. Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.
Martinez VD; Vucic EA; Pikor LA; Thu KL; Hubaux R; Lam WL
Mol Cancer; 2013 Oct; 12(1):124. PubMed ID: 24138990
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
Danilovic DLS; de Mello ES; Frazzato EST; Wakamatsu A; de Lima Jorge AA; Hoff AO; Marui S
Head Neck; 2018 Jun; 40(6):1271-1278. PubMed ID: 29469959
[TBL] [Abstract][Full Text] [Related]
7. The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases.
Dovinova I; Kvandová M; Balis P; Gresova L; Majzunova M; Horakova L; Chan JY; Barancik M
Physiol Res; 2020 Dec; 69(Suppl 4):S541-S553. PubMed ID: 33656904
[TBL] [Abstract][Full Text] [Related]
8.
Stuchi LP; Castanhole-Nunes MMU; Maniezzo-Stuchi N; Biselli-Chicote PM; Henrique T; Padovani Neto JA; de-Santi Neto D; Girol AP; Pavarino EC; Goloni-Bertollo EM
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32824922
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL.
Cha HY; Lee BS; Chang JW; Park JK; Han JH; Kim YS; Shin YS; Byeon HK; Kim CH
Cancer Lett; 2016 Mar; 372(1):65-74. PubMed ID: 26721202
[TBL] [Abstract][Full Text] [Related]
10. The dual role of Nrf2 in melanoma: a systematic review.
Malakoutikhah Z; Mohajeri Z; Dana N; Haghjooy Javanmard S
BMC Mol Cell Biol; 2023 Feb; 24(1):5. PubMed ID: 36747120
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress responses and NRF2 in human leukaemia.
Abdul-Aziz A; MacEwan DJ; Bowles KM; Rushworth SA
Oxid Med Cell Longev; 2015; 2015():454659. PubMed ID: 25918581
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans.
Prasad KN
J Am Coll Nutr; 2016; 35(2):175-84. PubMed ID: 26151600
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic role of baicalein in combating experimental periodontitis with diabetes via Nrf2 antioxidant signaling pathway.
Zhu C; Zhao Y; Wu X; Qiang C; Liu J; Shi J; Gou J; Pei D; Li A
J Periodontal Res; 2020 Jun; 55(3):381-391. PubMed ID: 31854466
[TBL] [Abstract][Full Text] [Related]
14. Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium.
Muthusamy VR; Kannan S; Sadhaasivam K; Gounder SS; Davidson CJ; Boeheme C; Hoidal JR; Wang L; Rajasekaran NS
Free Radic Biol Med; 2012 Jan; 52(2):366-76. PubMed ID: 22051043
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of Nrf2 and ERK pathway in papillary thyroid carcinoma].
Chen YM; Wei L; Lin X; Zhang WJ; Wu JF; Xue G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(12):941-945. PubMed ID: 29798417
[No Abstract] [Full Text] [Related]
16. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
Gong Y; Yang Y
Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
[TBL] [Abstract][Full Text] [Related]
17. Selenium protects against Pb-induced renal oxidative injury in weaning rats and human renal tubular epithelial cells through activating NRF2.
Tian C; Qiu Y; Zhao Y; Fu L; Xia D; Ying J
J Trace Elem Med Biol; 2024 May; 83():127420. PubMed ID: 38432121
[TBL] [Abstract][Full Text] [Related]
18. Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells.
Yang X; Wang D; Ma Y; Xu X; Zhu Z; Wang X; Deng H; Li C; Chen M; Tong J; Yamanaka K; An Y
Toxicol Appl Pharmacol; 2015 Dec; 289(2):231-9. PubMed ID: 26420645
[TBL] [Abstract][Full Text] [Related]
19. Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.
Zhang R; Xu M; Wang Y; Xie F; Zhang G; Qin X
Mol Neurobiol; 2017 Oct; 54(8):6006-6017. PubMed ID: 27696223
[TBL] [Abstract][Full Text] [Related]
20. AMPK/p38/Nrf2 activation as a protective feedback to restrain oxidative stress and inflammation in microglia stimulated with sodium fluoride.
Song C; Heping H; Shen Y; Jin S; Li D; Zhang A; Ren X; Wang K; Zhang L; Wang J; Shi D
Chemosphere; 2020 Apr; 244():125495. PubMed ID: 31837563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
